Gaucher Disease, Type 3
Also known as: Gaucher's disease type III / Gaucher Disease, Type III / Gaucher Disease Type 3 / Type 3 Gaucher disease / Subacute neuronopathic Gaucher's disease (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00053 | Imiglucerase | A form of recombinant human beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease. |
DB08876 | Taliglucerase alfa | A hydrolytic lysosomal glucocerebroside specific enzyme, used for long term enzyme replacement therapy in patients with Type 1 Gaucher disease. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00053 | Imiglucerase | Glucocerebroside | target |
DB08876 | Taliglucerase alfa | Glucocerebroside | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01272 | Alglucosidase alfa | 1 | Recruiting | 1 |
DB09051 | Elosulfase alfa | 1 | Recruiting | 1 |
DB01279 | Galsulfase | 1 | Recruiting | 1 |
DB01271 | Idursulfase | 1 | Recruiting | 1 |
DB00090 | Laronidase | 1 | Recruiting | 1 |
DB11563 | Sebelipase alfa | 1 | Recruiting | 1 |
DB12366 | Vestronidase alfa | 1 | Recruiting | 1 |
DB05543 | Velaglucerase alfa | 1 / 2 | Completed | 1 |
DB06720 | Velaglucerase alfa | 1 / 2 | Completed | 1 |
DB05025 | Arimoclomol | 2 | Terminated | 1 |
DB00053 | Imiglucerase | 2 | Active Not Recruiting | 1 |
DB14966 | Venglustat | 2 | Active Not Recruiting | 1 |
DB17650 | AVR-RD-02 | 2 / 3 | Withdrawn | 1 |
DB00053 | Imiglucerase | 2 / 3 | Withdrawn | 1 |
DB08876 | Taliglucerase alfa | 2 / 3 | Withdrawn | 1 |
DB09039 | Eliglustat | 3 | Active Not Recruiting | 1 |
DB00053 | Imiglucerase | 3 | Active Not Recruiting | 1 |
DB00053 | Imiglucerase | 3 | Recruiting | 1 |
DB14966 | Venglustat | 3 | Recruiting | 1 |
DB11105 | Benzalkonium | 4 | Completed | 1 |
DB08876 | Taliglucerase alfa | 4 | Completed | 1 |
DB06720 | Velaglucerase alfa | 4 | Withdrawn | 1 |
DB09039 | Eliglustat | Not Available | Completed | 1 |